Investor Relations

Corporate Overview

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Latest Financial Results

Q1 2024

Quarter Ended Mar 31, 2024

News Icon

Latest News

LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital

Events Icon

Recent Event

Key Opinion Leader Presentation of Capstone Data from Phase 3 CLARITY Study

IR Contacts

Corporate

LENZ Therapeutics, Inc.
445 Marine View Ave.
Suite 320
Del Mar, CA 92014
T: 858-925-7000
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449

Connect With Us